FAM160A1-DT

Across TCGA pan-cancer cohorts, FAM160A1-DT RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated FAM160A1-DT data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher FAM160A1-DT RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM160A1-DT expression acts as an unfavorable survival marker, although some lineages such as READ and KIRC show a favorable association.

KICH, READ, and KIRC are the cancer types where FAM160A1-DT RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Quartile	All	0.495	1.000	.002	55	view →
READ	OS	Tertile	II,III,IV	0.804	0.240	.002	53	view →
KIRC	DFS	Quartile	All	0.929	0.815	<.001	43	view →
HNSC	OS	Quartile	All	0.438	0.784	<.001	37	view →
LGG	DFS	Quartile	All	0.618	0.765	<.001	36	view →
BRCA	DFS	Tertile	III,IV	0.928	0.793	.001	22	view →
SARC	OS	Tertile	All	0.413	0.687	.003	22	view →
ESCA	DFS	Tertile	All	1.000	0.347	.003	21	view →
COAD	OS	Quartile	IV	0.793	0.354	.003	19	view →
LUAD	DFS	Median	IV	0.711	0.300	.017	17	view →
STAD	DFS	Quartile	All	0.756	0.599	.007	14	view →
OV	DFS	Tertile	III,IV	0.416	0.333	.026	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

FAM160A1-DT–KICH (OS)

Open the KICH breakdown →